Acessibilidade / Reportar erro

Acetylsalicylic acid and clopidogrel in the prevention of stent thrombosis

LETTER TO THE EDITOR

Universidade de Caxias do Sul - UCS, Caxias do Sul, RS - Brazil

Mailing address

Keywords: Drug-eluting stents; aspirin/administration & dosage; clopidogrel; thrombosis.

Our team of studies in Ischemic Heart Disease congratulates the authors for the article "Effectiveness and Safety of Drug-Eluting stents in a Cardiology Department in Curitiba - PR"1 and the results obtained at their department.

It is known that the occurrence of stent thrombosis has often catastrophic consequences, such as acute vessel occlusion, or even sudden death2. Stent thrombosis is a topic that interests us, especially in the way we manage late thrombosis in drug-eluting stents. Therefore, we would like to know the authors' opinion about the routine use of acetylsalicylic acid and clopidogrel after the first year of drug-eluting stent implantation in order to avoid events due to late stent thrombosis.

References

  • 1. Braga CYY, Rivetti LA, Stella FP. Efetividade e segurança dos stents farmacológicos em um serviço de cardiologia em Curitiba-PR. Arq Bras Cardiol. 2010;95(1):3-11.
  • 2. Campos CAHM, Ribeiro EE, Lemos PA, Falcão JL, Spadaro AG, Kajita LJ, et al. Perfil de segurança dos stents farmacológicos nas síndromes coronárias agudas: dados do Registro INCOR. Rev Bras Cardiol Invas. 2008;16(3):289-94.
  • Acetylsalicylic acid and clopidogrel in the prevention of stent thrombosis

    Mariana Menegotto; Eduardo Maffini da Rosa; Marina Bertoni Guerra
  • Publication Dates

    • Publication in this collection
      03 Oct 2011
    • Date of issue
      June 2011
    Sociedade Brasileira de Cardiologia - SBC Avenida Marechal Câmara, 160, sala: 330, Centro, CEP: 20020-907, (21) 3478-2700 - Rio de Janeiro - RJ - Brazil, Fax: +55 21 3478-2770 - São Paulo - SP - Brazil
    E-mail: revista@cardiol.br